Endpoints News

Scholar Rock's SMA drug approved		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

Mon T W Th F

14 September, 2026

sponsored by

Join healthcare's #1 must-attend innovation event

HLTH USA convenes top healthcare professionals and innovators to shape the future of health through unparalleled networking, insightful discussions, and innovative solutions.

presented by

Forge Biologics A Member of Ajinomoto Bio-Pharma Services

Pacing the Journey: A Framework to Commercial Readiness

news

Seeking a fresh start, Novo drops the 'Nordisk'

Scholar Rock gets FDA nod for spinal muscular atrophy drug

AstraZeneca’s next-gen SERD disappoints in untreated advanced breast cancer

Sep 16

2:00 pm ET

Beyond ICD codes: Unlocking rare disease insights with genomics and claims-based data

in case you missed it

Alzheon outlines plans for major fundraising round despite Phase 3 miss for Alzheimer's drug

News Briefing

Yarrow brings in more cash; AbbVie drug succeeds in menstrual migraine trial

Peer Review

Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head

The benefits of next-generation peptides will be thinly spread

These parents didn’t know why their daughter was sick. They turned to AI to help solve the mystery.

The Boston Globe

We're a day away from our next China biotech debate, this time in Washington, DC. We're sold out, but a few final tickets may become available if you check here.